Articles From: Karnalyte Resources Inc. announces change of President & CEO to Kazakhstan Considers Dollar Bond Comeback -- 2nd Update


Karnalyte Resources Inc. announces change of President & CEO Canada NewsWire CALGARY , Sept.
Sign-up for Karnalyte Resources Inc. announces change of President & CEO investment picks
- Selinexor Demonstrates Clinical Activity in Prostate Cancer and other Solid Tumors - - Data from Ongoing Phase 1 Clinical Study Presented at ESMO 2014 - - Webcast Scheduled for Monday, September 29, 2014 at 4:30pm ET - NEWTON, Mass., Sept.
Sign-up for Karyopharm Announces Clinical Data for Selinexor (KPT-330) in Advanced Solid Tumors investment picks
NATICK, Mass., June 30, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced that the underwriters of its previously announced public offering of common stock have exercised their option to purchase an additional 397,087 shares of its common stock at a price of $42.50 per share before underwriting discounts.
Sign-up for Karyopharm Announces Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock investment picks
NEWTON, Mass., Sept.
Sign-up for Karyopharm Announces Three Clinical Data Presentations at ESMO 2014 investment picks
NEWTON, Mass., Aug.
Sign-up for Karyopharm Appoints Justin Renz Executive Vice President and Chief Financial Officer investment picks
NATICK, Mass., June 24, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, today announced the initiation of its Phase 2 study of Selinexor (KPT-330) in patients 60 years of age or older with relapsed or refractory acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy and/or transplantation.
Sign-up for Karyopharm Initiates Registration-Directed, Randomized Study of Selinexor (KPT-330) in Older Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) investment picks
NATICK, Mass., June 26, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced the pricing of its underwritten public offering of 2,647,247 shares of its common stock at a price of $42.50 per share before underwriting discounts.
Sign-up for Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock investment picks
NATICK, Mass., June 25, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced that it has commenced an underwritten public offering of 2,200,000 shares of its common stock.
Sign-up for Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock investment picks
NEWTON, Mass., Aug.
Sign-up for Karyopharm Therapeutics Reports Second Quarter Financial Results for 2014 investment picks
- Phase 1 Clinical Data in Prostate Cancer and Other Solid Tumors - NEWTON, Mass., Sept.
Sign-up for Karyopharm to Host Conference Call to Discuss Selinexor (KPT-330) Data Presented at ESMO 2014 investment picks
NEWTON, Mass., Aug.
Sign-up for Karyopharm to Host Second Quarter 2014 Earnings Call on August 7, 2014 investment picks
NEWTON, Mass., Aug.
Sign-up for Karyopharm to Present at the Wedbush 2014 Life Sciences Management Access Conference investment picks
- Reports Q2 2014 Kate Spade direct to consumer comparable sales growth of 30%, contributing to an increase of full year 2014 direct to consumer comparable sales growth guidance to a range of 15% to 17% - Total Company net sales increased $87 million, or 49%, to $266 million in Q2 2014 compared to Q2 2013 - Increases Total Company full year 2014 Adjusted EBITDA guidance to a range of $120 million - $130 million from the previously guided range of $115 million - $125 million and adjusts targeted full year 2014 Kate Spade Brand Adjusted EBITDA margin expansion to approximately 50bps NEW YORK , Aug.
Sign-up for Kate Spade & Company Reports 2nd Quarter And First Half 2014 Results investment picks
NEW YORK (MarketWatch) -- Shares of Kate Spade (KATE) soared 9.8% in premarket trade Tuesday, putting them on track to open at the highest level seen since April 2007, after the handbags and accessories maker reported better-than-expected second-quarter profit and sales.
Sign-up for Kate Spade shares soar after better-than-expected profit, sales investment picks
2014/8/20
Kate Upton returns for a third season as the face of Sam Edelman’s fall advertising campaign.
Sign-up for Kate Upton Returns as Face of Sam Edelman, Fall 2014 investment picks
Rovi Corporation (NASDAQ: ROVI) today announced that Kathy Weidman has joined the company as senior vice president and general manager, metadata.
Sign-up for Kathy Weidman Joins Rovi as Senior Vice President and General Manager, Metadata investment picks
2014/9/24
Olay, the world’s number one female facial skincare brand, today announces actress Katie Holmes as the brand’s first Global Brand Ambassador.
Sign-up for Katie Holmes Glows as the First Olay Global Brand Ambassador investment picks
2014/8/11
BRIDGETON, Mo.
Sign-up for Katy Industries, Inc. Reports Net Income In 2014 Second Quarter Results investment picks
Magellan Health, Inc. (NASDAQ: MGLN) today announced that Kay Coles James, president of the Gloucester Institute, a non-profit organization focused on developing future African-American leaders, has been appointed to the Magellan Health board of directors.
Sign-up for Kay Coles James Joins Magellan Health Board of Directors investment picks
(NYSE:KED) Kayne Anderson Energy Development Company (the “Company”) today announced its financial results for the quarter ended May 31, 2014.
Sign-up for Kayne Anderson Energy Development Company Announces Results for the Quarter Ended May 31, 2014 investment picks
(NYSE:KED) Kayne Anderson Energy Development Company (the “Company” or “KED”) announced today that it has entered into a $70 million secured term loan (the “Term Loan”) as part of an amendment to its existing secured credit facility (the “Credit Facility”). All of the proceeds from the Term Loan were used to partially repay amounts borrowed on the Company’s existing $120 million secured revolving credit facility (the “Revolving Facility”). Outstanding loan balances on the Term Loan accrue interest daily at a rate equal to one-month LIBOR plus 1.35%. The interest rate of the Revolving Facility was unchanged at one-month LIBOR plus 1.60%. The Term Loan matures on August 28, 2018, and as part of the amendment to the Credit Facility, the maturity date of the Revolving Facility was extended to August 28, 2017.
Sign-up for Kayne Anderson Energy Development Company Enters into $70 Million Term Loan and Extends Maturity of Revolving Credit Facility investment picks
Kayne Anderson Energy Total Return Fund, Inc. (the “Fund”) (NYSE:KYE) announced that it completed a private placement of $70 million of unsecured notes (“Notes”) with an institutional investor.
Sign-up for Kayne Anderson Energy Total Return Fund Completes a Private Placement of $70 Million of Notes investment picks
Kayne Anderson Energy Total Return Fund, Inc. (the “Fund”) (NYSE:KYE) announced that it reached a conditional agreement with an institutional investor relating to a private placement of $70 million of unsecured notes (“Notes”). The Notes will mature seven years from issuance and pay interest at a rate of 3.36% per annum.
Sign-up for Kayne Anderson Energy Total Return Fund Prices a Private Placement of $70 Million of Notes investment picks
Kayne Anderson Energy Total Return Fund, Inc. (the “Fund”) (NYSE:KYE) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of July 31, 2014.
Sign-up for Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at July 31, 2014 investment picks
Kayne Anderson Midstream/Energy Fund, Inc. (the “Fund”) (NYSE:KMF) announced today that it has entered into a $50 million unsecured revolving credit agreement (the “Bank Facility”) with Sumitomo Mitsui Banking Corporation.
Sign-up for Kayne Anderson Midstream/Energy Fund Enters into $50 Million Unsecured Bank Facility investment picks
Kayne Anderson Midstream/Energy Fund, Inc. (the “Fund”) (NYSE:KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of July 31, 2014.
Sign-up for Kayne Anderson Midstream/Energy Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios at July 31, 2014 investment picks
Kayne Anderson MLP Investment Company (the “Company”) (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of July 31, 2014.
Sign-up for Kayne Anderson MLP Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at July 31, 2014 investment picks
2014/8/18
The new creative, the first for PUR since 2008, will introduce an original water critic character named Arthur Tweedie SOUTHBOROUGH, Mass.
Sign-up for Kaz To Unveil Bold New Creative Marketing Campaign For PUR Water Filtration investment picks
2014/9/25
By Josie Cox Kazakhstan is preparing to tap the international bond market for the first time in more than a decade, building on a rush of risky government borrowers that have issued debt in recent months to satisfy investors' thirst for high returns.
Sign-up for Kazakhstan Considers Dollar Bond Comeback -- 2nd Update investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Karnalyte Resources Inc. announces change of President & CEO to Kazakhstan Considers Dollar Bond Comeback -- 2nd Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices